{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:06:42Z","timestamp":1792026402702,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2022KY236"],"award-info":[{"award-number":["2022KY236"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Contrast-induced acute kidney injury (CI-AKI) is the third most common cause of hospital-acquired AKI. However, there is a paucity of efficacious interventions for the management\u00a0of CI-AKI. Here, we aim to investigate the effects of JQ1 in CI-AKI and provide theoretical data and a \u00a0foundation for \u00a0novel ideas for the clinical treatment of CI-AKI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, we performed in vivo and in vitro experiments with mice and\u00a0HK2 cells injury models respectively. The levels of serum creatinine (Cr) and blood urea nitrogen (BUN) were determined by an automatic analyzer for the measurements of renal function. The viability of HK-2 cells was analyzed using the Cell Counting Kit-8 (CCK-8) kit. Additionally, the kidney changes in the mice were detected using histopathology (H&amp;E) and immunofluorescent staining. The mRNA and protein expressions were assessed using Quantitative real-time PCR and western blot, respectively. Autophagy and apoptosis was analyzed by Transmission electron microscopy (TEM) and TUNEL assay respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The results\u00a0demonstrated that\u00a0JQ1 exhibited potency of attenuating CI-AKI in\u00a0mouse and HK2 cells. JQ1 increased the expression levels of Atg5, Atg7 and LC3B-II, and decreased the protein levels of p62 in the kidney and HK-2 cells. However, the combined use of JQ1 with chloroquine reversed the effects of JQ1. JQ1 also inhibited the inflammatory cells and downregulated the expression of some inflammatory cytokines (IL-6, IL-1\u03b2, TNF-\u03b1, and IFN-\u03b3).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>JQ1 protects against CI-AKI by promoting autophagy and inhibiting inflammation and JQ1 may be a promising therapeutic strategy for CI-AKI.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11255-023-03718-7","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T15:01:47Z","timestamp":1691420507000},"page":"739-749","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["JQ1 attenuates contrast-induced acute kidney injury through the upregulation of autophagy and inhibition of inflammation"],"prefix":"10.1007","volume":"56","author":[{"given":"Linghong","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danqing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,7]]},"reference":[{"issue":"3","key":"3718_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrneph.2016.196","volume":"13","author":"M Fahling","year":"2017","unstructured":"Fahling M, Seeliger E, Patzak A, Persson PB (2017) Understanding and preventing contrast-induced acute kidney injury. Nat Rev Nephrol 13(3):169\u2013180","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"3718_CR2","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1161\/CIR.0000000000000366","volume":"133","author":"D Mozaffarian","year":"2016","unstructured":"M. Writing Group, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB, C. American Heart Association Statistics, S. Stroke Statistics (2016) Executive summary: heart disease and stroke statistics\u20132016 update: a report from the American Heart Association. Circulation 133(4):447\u2013454","journal-title":"Circulation"},{"key":"3718_CR3","doi-asserted-by":"publisher","first-page":"934947","DOI":"10.1155\/2014\/934947","volume":"2014","author":"R Solomon","year":"2014","unstructured":"Solomon R (2014) Contrast media: are there differences in nephrotoxicity among contrast media? Biomed Res Int 2014:934947","journal-title":"Biomed Res Int"},{"issue":"3","key":"3718_CR4","doi-asserted-by":"publisher","first-page":"e006989","DOI":"10.1136\/bmjopen-2014-006989","volume":"5","author":"B Zhang","year":"2015","unstructured":"Zhang B, Liang L, Chen W, Liang C, Zhang S (2015) The efficacy of sodium bicarbonate in preventing contrast-induced nephropathy in patients with pre-existing renal insufficiency: a meta-analysis. BMJ Open 5(3):e006989","journal-title":"BMJ Open"},{"issue":"6","key":"3718_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.7326\/M15-1456","volume":"164","author":"RM Subramaniam","year":"2016","unstructured":"Subramaniam RM, Suarez-Cuervo C, Wilson RF, Turban S, Zhang A, Sherrod C, Aboagye J, Eng J, Choi MJ, Hutfless S, Bass EB (2016) Effectiveness of prevention strategies for contrast-induced nephropathy: a systematic review and meta-analysis. Ann Intern Med 164(6):406\u2013416","journal-title":"Ann Intern Med"},{"issue":"10","key":"3718_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3109\/0886022X.2015.1012985","volume":"37","author":"X Kang","year":"2015","unstructured":"Kang X, Hu DY, Li CB, Ai ZS, Peng A (2015) N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and meta-analysis. Ren Fail 37(10):297\u2013303","journal-title":"Ren Fail"},{"issue":"7","key":"3718_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1710933","volume":"378","author":"SD Weisbord","year":"2018","unstructured":"Weisbord SD, Gallagher M, Jneid H, Garcia S, Cass A, Thwin SS, Conner TA, Chertow GM, Bhatt DL, Shunk K, Parikh CR, McFalls EO, Brophy M, Ferguson R, Wu H, Androsenko M, Myles J, Kaufman J, Palevsky PM, P.T. Group (2018) Outcomes after angiography with sodium bicarbonate and acetylcysteine. N Engl J Med 378(7):603\u2013614","journal-title":"N Engl J Med"},{"key":"3718_CR8","doi-asserted-by":"publisher","first-page":"118379","DOI":"10.1016\/j.lfs.2020.118379","volume":"259","author":"F Zhang","year":"2020","unstructured":"Zhang F, Lu Z, Wang F (2020) Advances in the pathogenesis and prevention of contrast-induced nephropathy. Life Sci 259:118379","journal-title":"Life Sci"},{"issue":"7327","key":"3718_CR9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I, Philpott M, Munro S, McKeown MR, Wang Y, Christie AL, West N, Cameron MJ, Schwartz B, Heightman TD, La Thangue N, French CA, Wiest O, Kung AL, Knapp S, Bradner JE (2010) Selective inhibition of BET bromodomains. Nature 468(7327):1067\u20131073","journal-title":"Nature"},{"issue":"9","key":"3718_CR10","first-page":"491","volume":"73","author":"X Shi","year":"2018","unstructured":"Shi X, Liu C, Liu B, Chen J, Wu X, Gong W (2018) JQ1: a novel potential therapeutic target. Pharmazie 73(9):491\u2013493","journal-title":"Pharmazie"},{"key":"3718_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2020.09.003","volume":"149","author":"J Mu","year":"2020","unstructured":"Mu J, Zhang D, Tian Y, Xie Z, Zou MH (2020) BRD4 inhibition by JQ1 prevents high-fat diet-induced diabetic cardiomyopathy by activating PINK1\/Parkin-mediated mitophagy in vivo. J Mol Cell Cardiol 149:1\u201314","journal-title":"J Mol Cell Cardiol"},{"issue":"10","key":"3718_CR12","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1002\/cam4.2385","volume":"8","author":"F Li","year":"2019","unstructured":"Li F, Yang C, Zhang HB, Ma J, Jia J, Tang X, Zeng J, Chong T, Wang X, He D, Guo P (2019) BET inhibitor JQ1 suppresses cell proliferation via inducing autophagy and activating LKB1\/AMPK in bladder cancer cells. Cancer Med 8(10):4792\u20134805","journal-title":"Cancer Med"},{"key":"3718_CR13","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3389\/fimmu.2019.00933","volume":"10","author":"A Maksylewicz","year":"2019","unstructured":"Maksylewicz A, Bysiek A, Lagosz KB, Macina JM, Kantorowicz M, Bereta G, Sochalska M, Gawron K, Chomyszyn-Gajewska M, Potempa J, Grabiec AM (2019) BET bromodomain inhibitors suppress inflammatory activation of gingival fibroblasts and epithelial cells from periodontitis patients. Front Immunol 10:933","journal-title":"Front Immunol"},{"issue":"10","key":"3718_CR14","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.4049\/jimmunol.1502261","volume":"196","author":"J Chen","year":"2016","unstructured":"Chen J, Wang Z, Hu X, Chen R, Romero-Gallo J, Peek RM Jr, Chen LF (2016) BET inhibition attenuates helicobacter pylori-induced inflammatory response by suppressing inflammatory gene transcription and enhancer activation. J Immunol 196(10):4132\u20134142","journal-title":"J Immunol"},{"key":"3718_CR15","doi-asserted-by":"crossref","unstructured":"Bhatia D, Chung KP, Nakahira K, Patino E, Rice MC, Torres LK, Muthukumar T, Choi AM, Akchurin OM, Choi ME (2019) Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis. JCI Insight 4(23)","DOI":"10.1172\/jci.insight.132826"},{"issue":"4","key":"3718_CR16","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.kint.2015.11.021","volume":"89","author":"GP Kaushal","year":"2016","unstructured":"Kaushal GP, Shah SV (2016) Autophagy in acute kidney injury. Kidney Int 89(4):779\u2013791","journal-title":"Kidney Int"},{"issue":"38","key":"3718_CR17","doi-asserted-by":"publisher","first-page":"7974","DOI":"10.2174\/0929867328666210526125023","volume":"28","author":"X Liu","year":"2021","unstructured":"Liu X, Li Q, Sun L, Chen L, Li Y, Huang B, Liu Y, Jiang C (2021) miR-30e-5p regulates autophagy and apoptosis by targeting beclin1 involved in contrast-induced acute kidney injury. Curr Med Chem 28(38):7974\u20137984","journal-title":"Curr Med Chem"},{"issue":"13","key":"3718_CR18","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.jacc.2016.05.099","volume":"68","author":"PA McCullough","year":"2016","unstructured":"McCullough PA, Choi JP, Feghali GA, Schussler JM, Stoler RM, Vallabahn RC, Mehta A (2016) Contrast-induced acute kidney injury. J Am Coll Cardiol 68(13):1465\u20131473","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"3718_CR19","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1080\/15548627.2020.1848971","volume":"17","author":"Q Lin","year":"2021","unstructured":"Lin Q, Li S, Jiang N, Jin H, Shao X, Zhu X, Wu J, Zhang M, Zhang Z, Shen J, Zhou W, Gu L, Lu R, Ni Z (2021) Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy. Autophagy 17(10):2975\u20132990","journal-title":"Autophagy"},{"issue":"1","key":"3718_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1148\/radiol.13130775","volume":"271","author":"JS McDonald","year":"2014","unstructured":"McDonald JS, McDonald RJ, Carter RE, Katzberg RW, Kallmes DF, Williamson EE (2014) Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. Radiology 271(1):65\u201373","journal-title":"Radiology"},{"key":"3718_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ejrad.2019.03.008","volume":"116","author":"AL Faucon","year":"2019","unstructured":"Faucon AL, Bobrie G, Clement O (2019) Nephrotoxicity of iodinated contrast media: from pathophysiology to prevention strategies. Eur J Radiol 116:231\u2013241","journal-title":"Eur J Radiol"},{"issue":"12","key":"3718_CR22","doi-asserted-by":"publisher","first-page":"e2100180","DOI":"10.1002\/bies.202100180","volume":"43","author":"Y Liang","year":"2021","unstructured":"Liang Y, Tian J, Wu T (2021) BRD4 in physiology and pathology: \u201cBET\u201d on its partners. BioEssays 43(12):e2100180","journal-title":"BioEssays"},{"key":"3718_CR23","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.2147\/IJGM.S341072","volume":"15","author":"Q Li","year":"2022","unstructured":"Li Q, Pan S (2022) Contrast-associated acute kidney injury: advances and challenges. Int J Gen Med 15:1537\u20131546","journal-title":"Int J Gen Med"},{"key":"3718_CR24","doi-asserted-by":"publisher","first-page":"101254","DOI":"10.1016\/j.redox.2019.101254","volume":"26","author":"Q Lin","year":"2019","unstructured":"Lin Q, Li S, Jiang N, Shao X, Zhang M, Jin H, Zhang Z, Shen J, Zhou Y, Zhou W, Gu L, Lu R, Ni Z (2019) PINK1-parkin pathway of mitophagy protects against contrast-induced acute kidney injury via decreasing mitochondrial ROS and NLRP3 inflammasome activation. Redox Biol 26:101254","journal-title":"Redox Biol"},{"key":"3718_CR25","doi-asserted-by":"publisher","first-page":"7627934","DOI":"10.1155\/2020\/7627934","volume":"2020","author":"E Bae","year":"2020","unstructured":"Bae E, Kim JH, Jung MH, Jang SJ, Lee TW, Jung S, Lee S, Jang HN, Chang SH, Park DJ (2020) Paricalcitol attenuates contrast-induced acute kidney injury by regulating mitophagy and senescence. Oxid Med Cell Longev 2020:7627934","journal-title":"Oxid Med Cell Longev"},{"issue":"11","key":"3718_CR26","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1097\/TP.0000000000003319","volume":"104","author":"J Chen","year":"2020","unstructured":"Chen J, Miao X, Liu C, Liu B, Wu X, Kong D, Sun Q, Gong W (2020) BET protein inhibition prolongs cardiac transplant survival via enhanced myocardial autophagy. Transplantation 104(11):2317\u20132326","journal-title":"Transplantation"},{"key":"3718_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ebiom.2017.02.009","volume":"17","author":"Z Lu","year":"2017","unstructured":"Lu Z, Cheng D, Yin J, Wu R, Zhang G, Zhao Q, Wang N, Wang F, Liang M (2017) Antithrombin III protects against contrast-induced nephropathy. EBioMedicine 17:101\u2013107","journal-title":"EBioMedicine"},{"key":"3718_CR28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ebiom.2016.05.017","volume":"9","author":"F Wang","year":"2016","unstructured":"Wang F, Yin J, Lu Z, Zhang G, Li J, Xing T, Zhuang S, Wang N (2016) Limb ischemic preconditioning protects against contrast-induced nephropathy via renalase. EBioMedicine 9:356\u2013365","journal-title":"EBioMedicine"},{"issue":"7","key":"3718_CR29","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1172\/JCI96640","volume":"128","author":"A Lau","year":"2018","unstructured":"Lau A, Chung H, Komada T, Platnich JM, Sandall CF, Choudhury SR, Chun J, Naumenko V, Surewaard BG, Nelson MC, Ulke-Lemee A, Beck PL, Benediktsson H, Jevnikar AM, Snelgrove SL, Hickey MJ, Senger DL, James MT, Macdonald JA, Kubes P, Jenne CN, Muruve DA (2018) Renal immune surveillance and dipeptidase-1 contribute to contrast-induced acute kidney injury. J Clin Invest 128(7):2894\u20132913","journal-title":"J Clin Invest"},{"issue":"7","key":"3718_CR30","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1177\/0022034514534261","volume":"93","author":"S Meng","year":"2014","unstructured":"Meng S, Zhang L, Tang Y, Tu Q, Zheng L, Yu L, Murray D, Cheng J, Kim SH, Zhou X, Chen J (2014) BET inhibitor JQ1 blocks inflammation and bone destruction. J Dent Res 93(7):657\u2013662","journal-title":"J Dent Res"},{"key":"3718_CR31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13578-018-0258-7","volume":"8","author":"H Wang","year":"2018","unstructured":"Wang H, Huang W, Liang M, Shi Y, Zhang C, Li Q, Liu M, Shou Y, Yin H, Zhu X, Sun X, Hu Y, Shen Z (2018) (+)-JQ1 attenuated LPS-induced microglial inflammation via MAPK\/NFkappaB signaling. Cell Biosci 8:60","journal-title":"Cell Biosci"},{"issue":"1","key":"3718_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/resp.12872","volume":"22","author":"S Mumby","year":"2017","unstructured":"Mumby S, Gambaryan N, Meng C, Perros F, Humbert M, Wort SJ, Adcock IM (2017) Bromodomain and extra-terminal protein mimic JQ1 decreases inflammation in human vascular endothelial cells: implications for pulmonary arterial hypertension. Respirology 22(1):157\u2013164","journal-title":"Respirology"},{"issue":"9","key":"3718_CR33","doi-asserted-by":"publisher","first-page":"985","DOI":"10.2174\/1567205013666160427101832","volume":"13","author":"M Magistri","year":"2016","unstructured":"Magistri M, Velmeshev D, Makhmutova M, Patel P, Sartor GC, Volmar CH, Wahlestedt C, Faghihi MA (2016) The BET-bromodomain inhibitor JQ1 reduces inflammation and Tau phosphorylation at Ser396 in the brain of the 3xTg model of Alzheimer\u2019s disease. Curr Alzheimer Res 13(9):985\u2013995","journal-title":"Curr Alzheimer Res"},{"issue":"2","key":"3718_CR34","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1681\/ASN.2015080910","volume":"28","author":"B Suarez-Alvarez","year":"2017","unstructured":"Suarez-Alvarez B, Morgado-Pascual JL, Rayego-Mateos S, Rodriguez RM, Rodrigues-Diez R, Cannata-Ortiz P, Sanz AB, Egido J, Tharaux PL, Ortiz A, Lopez-Larrea C, Ruiz-Ortega M (2017) Inhibition of bromodomain and extraterminal domain family proteins ameliorates experimental renal damage. J Am Soc Nephrol 28(2):504\u2013519","journal-title":"J Am Soc Nephrol"},{"key":"3718_CR35","doi-asserted-by":"publisher","first-page":"101195","DOI":"10.1016\/j.redox.2019.101195","volume":"24","author":"H Liu","year":"2019","unstructured":"Liu H, Wang L, Weng X, Chen H, Du Y, Diao C, Chen Z, Liu X (2019) Inhibition of Brd4 alleviates renal ischemia\/reperfusion injury-induced apoptosis and endoplasmic reticulum stress by blocking FoxO4-mediated oxidative stress. Redox Biol 24:101195","journal-title":"Redox Biol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03718-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-023-03718-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03718-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T17:10:12Z","timestamp":1706116212000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-023-03718-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,7]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["3718"],"URL":"https:\/\/doi.org\/10.1007\/s11255-023-03718-7","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,7]]},"assertion":[{"value":"15 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}